Summer Rosenstock, PhD, MHS; Allison Ingalls, MPH; Reese Foy Cuddy, MPH; et al.
JAMA Pediatr. 2021;175(2):133-142. doi:10.1001/jamapediatrics.2020.3557
This randomized clinical trial assesses the impact of a brief home-visiting approach, Family Spirit Nurture, on sugar-sweetened beverage consumption, responsive parenting and infant feeding practices, and optimal infant growth through 12 months post partum.
Russell M. Viner, PhD; Oliver T. Mytton, PhD; Chris Bonell, PhD; et al.
has active quiz
JAMA Pediatr. 2021;175(2):143-156. doi:10.1001/jamapediatrics.2020.4573
This systematic review and meta-analysis evaluates current evidence on the susceptibility to and transmission of severe acute respiratory syndrome coronavirus 2 among children and adolescents compared with adults.
Dani Dumitriu, MD, PhD; Ukachi N. Emeruwa, MD, MPH; Erin Hanft, MD; et al.
has active quiz
JAMA Pediatr. 2021;175(2):157-167. doi:10.1001/jamapediatrics.2020.4298
This cohort study describes the outcomes of neonates born to mothers with perinatal severe acute respiratory syndrome coronavirus 2 infection and the infection prevention and control practices associated with these outcomes.
Dustin D. Flannery, DO, MSCE; Ibukunoluwa C. Akinboyo, MD; Sagori Mukhopadhyay, MD, MMSc; et al.
JAMA Pediatr. 2021;175(2):168-175. doi:10.1001/jamapediatrics.2020.4719
This cohort study assesses the antibiotic susceptibility patterns of Escherichia coli among infants admitted to US neonatal intensive care units from 2009 to 2017.
L. Charles Bailey, MD, PhD; Hanieh Razzaghi, MPH; Evanette K. Burrows, MPH; et al.
has active quiz
JAMA Pediatr. 2021;175(2):176-184. doi:10.1001/jamapediatrics.2020.5052
This cohort study uses electronic health record data from PEDSnet to describe testing for severe acute respiratory syndrome coronavirus 2 and the epidemiology of infected patients.
Richard Miech, PhD; Adam Leventhal, PhD; Lloyd Johnston, PhD; et al.
JAMA Pediatr. 2021;175(2):185-190. doi:10.1001/jamapediatrics.2020.5667
This survey study presents nationally representative estimates of recent trends in adolescent nicotine vaping, perceived risk of harm from vaping, accessibility of vaping materials, as well as trends in use of specific vaping brands and flavors.
Anders Tidblad, MD, PhD; Matteo Bottai, PhD, ScD; Helle Kieler, MD, PhD; et al.
JAMA Pediatr. 2021;175(2):e205199. doi:10.1001/jamapediatrics.2020.5199
This cohort study investigates the long-term risk of overall and severe cardiovascular events in patients previously treated with recombinant human growth hormone in childhood and assesses whether these events are associated with treatment duration or dose.
Jing-Syuan Huang, MD; Fu-Chi Yang, MD, PhD; Wu-Chien Chien, PhD; et al.
JAMA Pediatr. 2021;175(2):e205371. doi:10.1001/jamapediatrics.2020.5371
This cohort study uses data from patients registered in the Taiwan National Health Insurance Research Database to investigate the risk of substance use disorder among patients with autism spectrum disorder compared with controls without autism.